VOBIT R 0.5MG (Repaglinide (0.5mg) + Voglibose (0.3mg))

Vobit R 0.5mg/0.3mg Tablet is a dual-action pharmaceutical formulation designed to assist in managing type 2 diabetes mellitus. It effectively regulates elevated blood sugar levels in the body following meals, particularly when other medications and a controlled diet are insufficient for maintaining normal glucose levels. This medication is intended for use after meals, and the appropriate dosage will be determined by your healthcare provider. It is crucial not to discontinue this treatment without first consulting your physician, as abrupt cessation may lead to increased blood sugar levels, which could result in severe complications such as renal impairment and vision loss. In instances where a dose is missed, do not take it between meals; instead, wait until your subsequent meal to consume it, as taking a double dose in an attempt to compensate for the missed one is not advised. This medication should be integrated into a comprehensive treatment strategy that includes a balanced diet, consistent physical activity, and weight management, as recommended by your healthcare provider. Common adverse reactions associated with this medication may include flatulence, gastrointestinal disturbances such as diarrhea and abdominal discomfort, hypoglycemia, and skin rashes. These effects are generally transient and should resolve without intervention. Nonetheless, if these symptoms persist or cause concern, seek guidance from your doctor. Regular monitoring of blood sugar levels is essential while undergoing treatment with this medication. Prior to initiating therapy, patients should discuss any existing kidney or liver ailments or urinary tract infections with their healthcare provider, as well as the use of diuretics. Pregnant or lactating individuals should also seek medical advice before usage. It is advisable to avoid excessive alcohol consumption while on this medication, as this may heighten the risk of adverse effects.